ro7049389
Small moleculeexperimental
Clinical trial activity
6 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 31, 2016 (NCT02972255)
Timeline
Indications
Mechanism of action
- Hepatitis B virusINHIBITOR
Hepatitis B virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro7049389
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04729309 | Phase 1 | Mar 31, 2021 | Roche |
| NCT04225715 | Phase 2 | Apr 28, 2020 | Roche |
| NCT03717064 | Phase 1 | Nov 7, 2018 | Roche |
| NCT03570658 | Phase 1 | Aug 24, 2018 | Roche |
| NCT02952924 | Phase 1 | Dec 1, 2016 | Roche |
| NCT02972255 | Phase 1 | Oct 31, 2016 | Roche |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 6 | 6 | 2 | 2016 |
1 organizations
Page 1 / 1